Contact Us

Amiodarone
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

Which brand name of Amiodarone did you take?

Medical problems since taking Amiodarone:


What condition was this medication prescribed to treat?

Date you started taking this drug:

Date you stopped taking this drug:

Please further describe side effects:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Amiodarone


Facebook Twitter Stumble AddThis Social Bookmark Button Pin It Email to Friend Print Page

Amiodarone Side Effects May Link To Blindness Lawsuits

Amiodarone | Lawsuits, Lawyers | Side Effects: Blindness, Lung Damage, Toxic Epidermal Necrolysis (TEN)

The Food & Drug Administration (FDA) approved Amiodarone, manufactured by Wyeth, on January 5, 1999. Amiodarone is prescribed too treat heart rhythm disorders such as atrial fibrillation and atrial flutte. Doctors are prescribing this drug for off-label use without warning their patients about the drug's life-threatening side effects or that the FDA had not approved their treatment as safe and effective.

Amiodarone (brand names: Cordarone and Pacerone) has been linked to severe side effects such as blindness, lung damage, and Toxic Epidermal Necrolysis (TEN). Many patients some left blind or with severely damaged lungs say doctors or pharmacists never told them about the drug's life-threatening side effects or that the FDA hadn't approved the treatment as safe and effective.

Toxic Epidermal Necrolysis (TEN) is a rare condition that causes large portions of the epidermis, the skin's outermost layer, to disengage from the layers of skin below. The main cause of Toxic Epidermal Necrolysis (TEN) is a severe drug reaction.

In response to an investigation by Knight Ridder, that the FDA said it would require all Amiodarone prescriptions be dispensed with a special patient medication guide detailing the drug's dangers and what conditions it is approved to treat. Patients were supposed to begin receiving the FDA-approved warning guides by early 2004, however six months later they are still under development and not being disseminated.

Amiodarone can be highly toxic to patients and causes a wide range of serious side effects. In some studies, as many as 17% of patients have experienced lung damage with 10% dying from it. Rarely do doctors inform patients of off-label prescribing, which means using a drug in ways the FDA never approved. While legal, such use can upset the balance between risk and benefit that's crucial to get a drug approved and on the market.

In 2004 doctors wrote nearly 2.3 million prescriptions for Amiodarone to treat atrial fibrillation and other unapproved conditions accounting for 82 percent of it sales, according to a Knight Ridder analysis of drug industry data published last fall.

Off-label prescribing involves a doctor using a drug in ways the FDA never approved and therefore aren't listed on its label. While going off-label is legal, such use can upset the balance between risk and benefit that is crucial to get a drug approved and on the market.

Legal Help For Victims Affected By Amiodarone

If you or a loved one took Amiodarone and suffered side effects, please fill out the form at the right for a free  case evaluation by a qualified drug side effects attorney or call us at 1-800-YOURLAWYER (1-800-968-7529).

AmiodaroneRSS Feed

FDA Launches Site to Warn Patients, Doctors of Drug Risks

May 20, 2005 | Knight Ridder Newspapers
The U.S. Food and Drug Administration has begun issuing alerts to patients and doctors on its Web site about emerging drug-safety concerns, including dangers posed by drugs prescribed for unapproved purposes.The new site, called Drug Watch, marks a significant change in how the agency communicates risks to the public. In the past, the FDA has spent months or years privately weighing and debating risk information with drug companies until a final determination was made on the scientific...

After A Long Delay, FDA Approves Warnings For Heart Drug

Dec 7, 2004 | Knight Ridder Newspapers
After a delay of more than a year, the Food and Drug Administration has approved publication of new patient warnings for a potentially risky heart drug that millions of Americans are taking. Patients taking amiodarone can read the new warnings on the Internet beginning next week and will soon start receiving paper copies when they get or refill prescriptions. The FDA's action comes two weeks after Knight Ridder reported the delay, prompting an outcry from readers who said they've lost loved...

Toxic Drug Lacks FDA Warning

Nov 24, 2004 | Knight Ridder
A highly toxic heart drug continues to be prescribed to millions of patients nationwide without the detailed consumer warnings promised by the U.S. Food and Drug Administration more than a year ago.Each bottle of the drug, amiodarone sold under the brand names Cordarone and Pacerone as well several generics is supposed to include a new advisory that warns of its risks and symptoms of fatal side effects and explains how the medication is supposed to be used. But the advisory, planned since...

What Are Amiodarone's Risks?

Nov 24, 2004 | Miami Herald
The drug's FDA-approved prescribing label for doctors, which patients rarely see, warns that the drug comes with ''substantial toxicity.'' About three-fourths of all patients taking a 400 mg dose experienced some side effects.Lung toxicity, which has harmed as many as 17 percent of patients in some studies and has been fatal about 10 percent of the time.Injury to the liver. While usually mild, it too can be fatal.Worsening of the heart rhythm problem.When given to pregnant women, the drug has...

PRESCRIPTION DRUGS Heart Patients Taking Potentially Lethal Drug

Nov 24, 2004 | Miami Hearald
A highly toxic heart drug continues to be prescribed to millions of patients nationwide without the detailed consumer warnings promised by the U.S. Food and Drug Administration more than a year ago.Each bottle of the drug, amiodarone, is supposed to include a new advisory that warns of its many risks and symptoms of fatal side effects and explains how the medication is supposed to be used. But the advisory, planned since October 2003, remains in draft form, bouncing back and forth between the...

More Amiodarone News

Parker Waichman Accolades And Reviews Law Dragon Best Lawyers Find Us On Avvo Protected by Copyscape Web Copyright Protection Software php-5